Synthesis of a divalent sialyl Lewis x O-glycan, a potent inhibitor of lymphocyte-endothelium adhesion. Evidence that multivalency enhances the saccharide binding to L-selectin.
about
Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectinsalpha 2,3-Sialylation of terminal GalNAc beta 1-3Gal determinants by ST3Gal II reveals the multifunctionality of the enzyme. The resulting Neu5Ac alpha 2-3GalNAc linkage is resistant to sialidases from Newcastle disease virus and Streptococcus pneumBiosynthesis of sialylated and fucosylated selectin ligands of HL-60 cells in vitro. Midchain alpha3-fucose units inhibit terminal alpha6-sialylation but not alpha3-sialylation of polylactosamines.The centrally acting beta1,6N-acetylglucosaminyltransferase (GlcNAc to gal). Functional expression, purification, and acceptor specificity of a human enzyme involved in midchain branching of linear poly-N-acetyllactosamines.Helicobacter pylori β1,3-N-acetylglucosaminyltransferase for versatile synthesis of type 1 and type 2 poly-LacNAcs on N-linked, O-linked and I-antigen glycans.Mannosylated mucin-type immunoglobulin fusion proteins enhance antigen-specific antibody and T lymphocyte responses.Characteristics of protein-carbohydrate interactions as a basis for developing novel carbohydrate-based antirejection therapies.ABO blood group glycans modulate sialic acid recognition on erythrocytes.Carbohydrate-PNA and aptamer-PNA conjugates for the spatial screening of lectins and lectin assemblies.Inhibition of L- and P-selectin by a rationally synthesized novel core 2-like branched structure containing GalNAc-Lewisx and Neu5Acalpha2-3Galbeta1-3GalNAc sequences.Inhibition of L-selectin-mediated leukocyte rolling by synthetic glycoprotein mimics.Human milk oligosaccharides reduce platelet-neutrophil complex formation leading to a decrease in neutrophil beta 2 integrin expression.A new generation of carbohydrate-based therapeutics: recombinant mucin-type fusion proteins as versatile inhibitors of protein-carbohydrate interactions.
P2860
Q24552437-5BA3E13D-D382-43DD-9F25-11624E4B2268Q30695535-6B2789BD-58A4-4186-98B7-A692C485B0C2Q30725103-287BEB8A-3563-43A9-A756-27262746A912Q32003138-6D9C6979-9B81-446D-8B9A-CDF194DFC4B8Q34333892-4C53957C-4EE1-445C-AC5C-C072838CFAB0Q34447658-CBD94061-055D-4B37-BF87-F2CA0ADCF23EQ36304925-D9F14A7C-AAF8-4C11-8B92-4A8B1CE656FBQ37398333-653F3D17-4284-4D20-BF84-FA6A9E77BDA3Q38318782-CB1840EB-2D27-4F80-96E8-5B78899ECE20Q38336780-D81C3E0D-BB38-4DC7-9C8F-02555E89C030Q40972025-66246A70-39D0-4F3D-B232-F5FCB068F62DQ44968945-F26A4B81-7BA1-4B55-9CC5-5603CB869AB8Q51171028-702AEB2D-6D80-4C8C-A93D-668EC8BE4993
P2860
Synthesis of a divalent sialyl Lewis x O-glycan, a potent inhibitor of lymphocyte-endothelium adhesion. Evidence that multivalency enhances the saccharide binding to L-selectin.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Synthesis of a divalent sialyl ...... charide binding to L-selectin.
@en
type
label
Synthesis of a divalent sialyl ...... charide binding to L-selectin.
@en
prefLabel
Synthesis of a divalent sialyl ...... charide binding to L-selectin.
@en
P2093
P2860
P1433
P1476
Synthesis of a divalent sialyl ...... charide binding to L-selectin.
@en
P2093
H Maaheimo
J P Turunen
L Penttilä
O Renkonen
R Renkonen
P2860
P304
P356
10.1111/J.1432-1033.1995.616_B.X
P407
P577
1995-12-01T00:00:00Z